Boston Family Office’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,251	Closed	-$354K	–	263
2023 Q2	$354K	Sell	4,251 -3,024	-42%	-$253K	0.03%	219
2023 Q1	$554K	Sell	7,275 -2,195	-23%	-$182K	0.04%	183
2022 Q4	$786K	Sell	9,470 -11,364	-55%	-$920K	0.07%	168
2022 Q3	$1.65M	Sell	20,834 -19,010	-48%	-$1.6M	0.15%	115
2022 Q2	$2.96M	Sell	39,844 -48,074	-55%	-$3.61M	0.25%	82
2022 Q1	$7.9M	Buy	87,918 +4,805	+6%	+$444K	0.56%	54
2021 Q4	$9.3M	Buy	83,113 +9,587	+13%	+$1.16M	0.61%	51
2021 Q3	$9.24M	Buy	73,526 +2,090	+3%	+$269K	0.67%	46
2021 Q2	$9.67M	Buy	71,436 +7,173	+11%	+$943K	0.69%	46
2021 Q1	$8.51M	Buy	64,263 +2,485	+4%	+$372K	0.64%	52
2020 Q4	$8.7M	Sell	61,778 -924	-1%	-$118K	0.67%	51
2020 Q3	$6.99M	Sell	62,702 -389	-0.6%	-$43.6K	0.63%	48
2020 Q2	$7.06M	Buy	63,091 +3,182	+5%	+$313K	0.69%	46
2020 Q1	$4.64M	Buy	59,909 +31	+0.1%	+$2.75K	0.55%	53
2019 Q4	$5.7M	Sell	59,878 -2,450	-4%	-$212K	0.54%	54
2019 Q3	$4.75M	Sell	62,328 -1,194	-2%	-$99.2K	0.49%	57
2019 Q2	$5.57M	Sell	63,522 -1,298	-2%	-$111K	0.58%	53
2019 Q1	$5.87M	Buy	64,820 +32,081	+98%	+$2.73M	0.63%	52
2018 Q4	$2.35M	Sell	32,739 -3,267	-9%	-$263K	0.29%	90
2018 Q3	$3.45M	Buy	36,006 +3,856	+12%	+$374K	0.36%	83
2018 Q2	$3.06M	Buy	+32,150	New	+$2.95M	0.35%	84